Home » Topics » BioWorld Science

BioWorld Science
RSS

Endothelial stress products in circulating blood as biomarkers for COVID-19

Dec. 22, 2020

Phase III HOPE-B study of etranacogene dezaparvovec meets first coprimary endpoint

Dec. 22, 2020

EC grants approval for Libmeldy gene therapy as treatment of early-onset MLD

Dec. 22, 2020

City of Hope National Medical Center divulges new CARs for treating T-cell lymphoma

Dec. 22, 2020

Aligos Therapeutics presents HBV and HDV antivirals

Dec. 22, 2020

Celgene synthesizes new CKI-alpha degradation inducers

Dec. 22, 2020

Pfizer/BioNTech COVID-19 vaccine receives conditional marketing authorization in Europe

Dec. 22, 2020

Sage Therapeutics has patented GABA(A) receptor modulators

Dec. 22, 2020

Enanta Pharmaceuticals divulges compounds for HBV infection

Dec. 22, 2020

Fintepla approved in Europe for the treatment of seizures in Dravet syndrome

Dec. 22, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...